Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="PELGRIMS, G*" or (type exact bookEditor and editor="PELGRIMS, G*")

Add to list
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Ignace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, Christof Vulsteke, Caroline Lamot, Heidi Van den Bulck, Nele Claes, Marie-Pascale Graas, Guy Debrock, Isabelle Spoormans, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 32(6). p.753-760
Add to list
An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations

Brant Delafontaine (UGent) , C. De Backer, B. Beuselinck, P. Debruyne, L. D’Hondt, C. Gennigens, T. Gil, C. Vulsteke, N. Martinez-Chanza, A. Verbiest, et al.

(2020) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 14(2). p.56-70
Add to list
Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?

Charles Van Praet (UGent) , Sylvie Rottey (UGent) , Fransien Van Hende, Gino Pelgrims, Wim Demey, Filip Van Aelst, Wim Wynendaele, Thierry Gil, Peter Schatteman, Bertrand Filleul, et al.

(2017) CLINICAL GENITOURINARY CANCER. 15(4). p.502-508
Add to list
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program

Charles Van Praet (UGent) , Sylvie Rottey (UGent) , Fransien Van Hende, Gino Pelgrims, Wim Demey, Filip Van Aelst, Wim Wynendaele, Thierry Gil, Peter Schatteman, Bertrand Filleul, et al.

(2016) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 34(6). p.254.e7-254.e13
Add to list
- Conference Paper
- C3
Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program

Sylvie Rottey (UGent) , Charles Van Praet (UGent) , Fransien Van Hende, Gino Pelgrims, Wim Demey, Filip Van Aelst, Wim Wynendaele, Thierry Gil, Peter Schatteman, Bertrand Filleul, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(15, suppl.).
Add to list
- Journal Article
- A1
Fulvestrant (Faslodex (TM)) in advanced breast cancer: clinical experience from a Belgian cooperative study

P NEVEN, R PARIDAENS, G PELGRIMS, M MARTENS, A BOLS, J GOEMINNE, A VINDEVOGHEL, J DEMOL, B STRAGIER, J DE GREVE, et al.

(2008) BREAST CANCER RESEARCH AND TREATMENT. 109(1). p.59-65
Add to list
- Conference Paper
- C3
Fulvestrant in heavily pretreated patients with advanced breast cancer: a Belgium cooperative study.

P NEVEN, R PARIDAENS, G PELGRIMS, M MARTENS, A BOLS, JC GOEMINNE, A VINDEVOGHEL, J DEMOL, B STRAGIER, J DE GREVE, et al.

(2006) BREAST CANCER RESEARCH AND TREATMENT. 100.

Academic Bibliography

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations

Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program

Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program

Fulvestrant (Faslodex (TM)) in advanced breast cancer: clinical experience from a Belgian cooperative study

Fulvestrant in heavily pretreated patients with advanced breast cancer: a Belgium cooperative study.

Contents

Support

Contact